These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30579841)

  • 1. Erratum to "Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature" [Clin. Res. Hepatol. Gastroenterol. 42 (2018) 604-609].
    Zullo A; Manta R; De Francesco V; Fiorini G; Lahner E; Vaira D; Annibale B
    Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):112-113. PubMed ID: 30579841
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum to "Systematic review of progressive familial intrahepatic cholestasis" [Clin. Res. Hepatol. Gastroenterol. 43 (2019) 20-36].
    Baker A; Kerkar N; Todorova L; Kamath BM; Houwen RHJ
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):115. PubMed ID: 31926839
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum to "IV Spanish Consensus Conference on Helicobacter pylori infection treatment" <[Gastroenterol Hepatol 39 (2016) 697-721]>.
    Gisbert JP; Molina-Infante J; Amador J; Bermejo F; Bujanda L; Calvet X; Castro-Fernández M; Cuadrado-Lavín A; Elizalde JI; Gene E; Gomollón F; Lanas Á; de Argila CM; Mearin F; Montoro M; Pérez-Aisa Á; Pérez-Trallero E; McNicholl AG
    Gastroenterol Hepatol; 2017 May; 40(5):378. PubMed ID: 28291549
    [No Abstract]   [Full Text] [Related]  

  • 4. Erratum to "Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease" <[Gastroenterol Hepatol 39 (2016) 571-573]>.
    Bruguera M; Jara P; Berenguer M; Mariño Z
    Gastroenterol Hepatol; 2017 May; 40(5):377. PubMed ID: 28365004
    [No Abstract]   [Full Text] [Related]  

  • 5. Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349].
    Aller R; Fernández-Rodríguez C; Lo Iacono O; Bañares R; Abad J; Carrión JA; García-Monzón C; Caballería J; Berenguer M; Rodríguez-Perálvarez M; López Miranda J; Vilar-Gómez E; Crespo J; García-Cortés M; Reig M; Navarro JM; Gallego-Durán R; Genescà J; Arias-Loste MT; Pareja MJ; Albillos A; Muntané J; Jorquera F; Solà E; Hernández-Guerra M; Rojo MÁ; Salmerón J; Caballería L; Diago M; Molina E; Bataller R; Romero-Gómez M
    Gastroenterol Hepatol; 2018; 41(7):475-476. PubMed ID: 29929828
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Reiss G, Ramrakhiani S. Right upper-quadrant pain and a normal abdominal ultrasound. Clin Gastroenterol Hepatol 2009;7:603.
    Ahmed F; Fogel E
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1256. PubMed ID: 19778633
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604.
    Caspersen S; Mortensen C; Riis L; Jess T; Bendtsen F
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1257. PubMed ID: 19778634
    [No Abstract]   [Full Text] [Related]  

  • 8. Erratum to 'Correspondence on Letter regarding "Evidence-based hyponatremia management in liver disease"' [Clin Mol Hepatol 2023;29:1048-1049].
    Baek SH; Ryu JY; Kim S
    Clin Mol Hepatol; 2024 Jan; 30(1):134. PubMed ID: 37935205
    [No Abstract]   [Full Text] [Related]  

  • 9. Erratum to 'History and future of hepatitis B virus control in South Korea' [Clin Mol Hepatol 2021;27:620-622].
    Kim DY
    Clin Mol Hepatol; 2022 Oct; 28(4):939. PubMed ID: 35748100
    [No Abstract]   [Full Text] [Related]  

  • 10. Erratum to 'KASL clinical practice guidelines for management of chronic hepatitis B' [Clin Mol Hepatol 2022;28:276-331].
    Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2022 Oct; 28(4):940. PubMed ID: 36068669
    [No Abstract]   [Full Text] [Related]  

  • 11. Erratum to 'Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?' [Clin Mol Hepatol 2023;29:367-370].
    Oh JH; Sinn DH
    Clin Mol Hepatol; 2023 Jul; 29(3):828-829. PubMed ID: 37344939
    [No Abstract]   [Full Text] [Related]  

  • 12. Erratum to 'Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction' [Clin Mol Hepatol 2024;30:539-560].
    Dezhbord M; Kim SH; Park S; Lee DR; Kim N; Won J; Lee AR; Kim DS; Kim KH
    Clin Mol Hepatol; 2024 Jul; ():. PubMed ID: 39044466
    [No Abstract]   [Full Text] [Related]  

  • 13. Erratum to 'Next-generation sequencing analysis of hepatitis C virus resistance-associated substitutions in directacting antiviral failure in South Korea' [Clin Mol Hepatol 2023;29:496-509].
    Kim KA; Lee S; Park HJ; Jang ES; Lee YJ; Cho SB; Kim YS; Kim IH; Lee BS; Chung WJ; Ahn SH; Kim S; Jeong SH
    Clin Mol Hepatol; 2023 Jul; 29(3):830. PubMed ID: 37344940
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum: Removal Notice to "Slimming to the Death: Herbalife® Associated Fatal Acute Liver Failure - Heavy Metals, Toxic Compounds, Bacterial Contaminants and Psychotropic Agents in Products Sold in India", [J Clin Exp Hepatol 9 (2019) 268-272].
    Philips CA; Augustine P; Rajesh S; John SK; Valiathan GC; Mathew J; Phalkey S; Antony KL
    J Clin Exp Hepatol; 2020; 10(1):100. PubMed ID: 32025170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to Lancet Gastroenterol Hepatol 2018; 3: 326-36.
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):e2. PubMed ID: 29644979
    [No Abstract]   [Full Text] [Related]  

  • 16. Correction to Lancet Gastroenterol Hepatol 2017; 2: 877-89.
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):e1. PubMed ID: 29254619
    [No Abstract]   [Full Text] [Related]  

  • 17. Correction to Lancet Gastroenterol Hepatol 2017; 2: 785-92.
    Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):e7. PubMed ID: 29017715
    [No Abstract]   [Full Text] [Related]  

  • 18. Correction to Lancet Gastroenterol Hepatol 2018; 3: 603-13.
    Lancet Gastroenterol Hepatol; 2018 Sep; 3(9):e4. PubMed ID: 30102185
    [No Abstract]   [Full Text] [Related]  

  • 19. Correction to Lancet Gastroenterol Hepatol 2018; 3: 593-95.
    Lancet Gastroenterol Hepatol; 2018 Oct; 3(10):e5. PubMed ID: 30215364
    [No Abstract]   [Full Text] [Related]  

  • 20. Correction to Lancet Gastroenterol Hepatol 2018; 3: 778-89.
    Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):e6. PubMed ID: 30353859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.